U.S. stocks were higher, with the Dow Jones index gaining more than 200 points on Friday.
Shares of Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) rose sharply during Friday’s session after the FDA approved PALSONIFY.
Where Today's News Shapes Tomorrow
U.S. stocks were higher, with the Dow Jones index gaining more than 200 points on Friday.
Shares of Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) rose sharply during Friday’s session after the FDA approved PALSONIFY.